APO Research

APO RESEARCH · REPORT

Nifedipine Injection

Selected research

Industry Growth & Trends

Global Nifedipine Injection Industry Growth and Trends Forecast to 2032

Market perspective

The global Nifedipine Injection market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Nifedipine Injection is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Nifedipine Injection is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Nifedipine Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Nifedipine Injection include Teva, Medcalo, Mylan, Pfizer, Cisen Pharmaceutical, Wuhan Binhu Shuanghe Pharmaceutical, Bayer, Pharmaoffer and AdvaCare, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Nifedipine Injection market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Nifedipine Injection market size, estimates, and forecasts are presented in terms of sales volume (L) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Nifedipine Injection market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Nifedipine Injection.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Nifedipine Injection market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Nifedipine Injection Market by Company

Teva

Medcalo

Mylan

Pfizer

Cisen Pharmaceutical

Wuhan Binhu Shuanghe Pharmaceutical

Bayer

Pharmaoffer

AdvaCare

Nifedipine Injection Segment by Type

10mg/2ml

20mg/2ml

Nifedipine Injection Segment by Application

Hypertension

Angina (Chest Pain)

Nifedipine Injection Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Nifedipine Injection market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Nifedipine Injection and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Nifedipine Injection.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Nifedipine Injection manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Nifedipine Injection in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of 10mg/2ml Table 2. Major Company of 20mg/2ml Table 3. Global Nifedipine Injection Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Nifedipine Injection Sales by Type (2021-2026) & (L) Table 5. Global Nifedipine Injection Sales Market Share in Volume by Type (2021-2026) Table 6. Global Nifedipine Injection Sales by Type (2021-2026) & (US$ Million) Table 7. Global Nifedipine Injection Sales Market Share in Value by Type (2021-2026) Table 8. Global Nifedipine Injection Price by Type (2021-2026) & (US$/ml) Table 9. Global Nifedipine Injection Sales by Type (2027-2032) & (L) Table 10. Global Nifedipine Injection Sales Market Share in Volume by Type (2027-2032) Table 11. Global Nifedipine Injection Sales by Type (2027-2032) & (US$ Million) Table 12. Global Nifedipine Injection Sales Market Share in Value by Type (2027-2032) Table 13. Global Nifedipine Injection Price by Type (2027-2032) & (US$/ml) Table 14. North America Nifedipine Injection Sales by Type (2021-2026) & (L) Table 15. North America Nifedipine Injection Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Nifedipine Injection Sales by Type (2021-2026) & (L) Table 17. Europe Nifedipine Injection Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Nifedipine Injection Sales by Type (2021-2026) & (L) Table 19. Asia-Pacific Nifedipine Injection Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Nifedipine Injection Sales by Type (2021-2026) & (L) Table 21. Latin America Nifedipine Injection Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Nifedipine Injection Sales by Type (2021-2026) & (L) Table 23. Middle East and Africa Nifedipine Injection Sales by Type (2021-2026) & (US$ Million) Table 24. Nifedipine Injection Industry Trends Table 25. Nifedipine Injection Industry Drivers Table 26. Nifedipine Injection Industry Opportunities and Challenges Table 27. Nifedipine Injection Industry Restraints Table 28. Global Nifedipine Injection Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Nifedipine Injection Revenue Market Share by Company (2021-2026) Table 30. Global Nifedipine Injection Sales by Company (2021-2026) & (L) Table 31. Global Nifedipine Injection Sales Share by Company (2021-2026) Table 32. Global Nifedipine Injection Market Price by Company (2021-2026) & (US$/ml) Table 33. Global Nifedipine Injection Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Nifedipine Injection Major Company Production Sites and Headquarters Table 35. Global Nifedipine Injection Company, Product Type & Application Table 36. Global Nifedipine Injection Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Nifedipine Injection by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Nifedipine Injection Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Nifedipine Injection Sales by Region (2021-2026) & (L) Table 41. Global Nifedipine Injection Sales Market Share in Volume by Region (2021-2026) Table 42. Global Nifedipine Injection Sales by Region (2021-2026) & (US$ Million) Table 43. Global Nifedipine Injection Sales Market Share in Value by Region (2021-2026) Table 44. Global Nifedipine Injection Sales (L), Value (US$ Million), Price (US$/ml) and Gross Margin (2021-2026) Table 45. Global Nifedipine Injection Sales by Region (2027-2032) & (L) Table 46. Global Nifedipine Injection Sales Market Share in Volume by Region (2027-2032) Table 47. Global Nifedipine Injection Sales by Region (2027-2032) & (US$ Million) Table 48. Global Nifedipine Injection Sales Market Share in Value by Region (2027-2032) Table 49. Global Nifedipine Injection Sales (L), Value (US$ Million), Price (US$/ml) and Gross Margin (2027-2032) Table 50. Global Nifedipine Injection Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Nifedipine Injection Sales by Application (2021-2026) & (L) Table 52. Global Nifedipine Injection Sales Market Share in Volume by Application (2021-2026) Table 53. Global Nifedipine Injection Sales by Application (2021-2026) & (US$ Million) Table 54. Global Nifedipine Injection Sales Market Share in Value by Application (2021-2026) Table 55. Global Nifedipine Injection Price by Application (2021-2026) & (US$/ml) Table 56. Global Nifedipine Injection Sales by Application (2027-2032) & (L) Table 57. Global Nifedipine Injection Sales Market Share in Volume by Application (2027-2032) Table 58. Global Nifedipine Injection Sales by Application (2027-2032) & (US$ Million) Table 59. Global Nifedipine Injection Sales Market Share in Value by Application (2027-2032) Table 60. Global Nifedipine Injection Price by Application (2027-2032) & (US$/ml) Table 61. North America Nifedipine Injection Sales by Application (2021-2026) & (L) Table 62. North America Nifedipine Injection Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Nifedipine Injection Sales by Application (2021-2026) & (L) Table 64. Europe Nifedipine Injection Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Nifedipine Injection Sales by Application (2021-2026) & (L) Table 66. Asia-Pacific Nifedipine Injection Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Nifedipine Injection Sales by Application (2021-2026) & (L) Table 68. Latin America Nifedipine Injection Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Nifedipine Injection Sales by Application (2021-2026) & (L) Table 70. Middle East and Africa Nifedipine Injection Sales by Application (2021-2026) & (US$ Million) Table 71. Teva Company Information Table 72. Teva Business Overview Table 73. Teva Nifedipine Injection Sales (L), Revenue (US$ Million), Price (US$/ml) and Gross Margin (2021-2026) Table 74. Teva Nifedipine Injection Product Portfolio Table 75. Teva Recent Development Table 76. Medcalo Company Information Table 77. Medcalo Business Overview Table 78. Medcalo Nifedipine Injection Sales (L), Revenue (US$ Million), Price (US$/ml) and Gross Margin (2021-2026) Table 79. Medcalo Nifedipine Injection Product Portfolio Table 80. Medcalo Recent Development Table 81. Mylan Company Information Table 82. Mylan Business Overview Table 83. Mylan Nifedipine Injection Sales (L), Revenue (US$ Million), Price (US$/ml) and Gross Margin (2021-2026) Table 84. Mylan Nifedipine Injection Product Portfolio Table 85. Mylan Recent Development Table 86. Pfizer Company Information Table 87. Pfizer Business Overview Table 88. Pfizer Nifedipine Injection Sales (L), Revenue (US$ Million), Price (US$/ml) and Gross Margin (2021-2026) Table 89. Pfizer Nifedipine Injection Product Portfolio Table 90. Pfizer Recent Development Table 91. Cisen Pharmaceutical Company Information Table 92. Cisen Pharmaceutical Business Overview Table 93. Cisen Pharmaceutical Nifedipine Injection Sales (L), Revenue (US$ Million), Price (US$/ml) and Gross Margin (2021-2026) Table 94. Cisen Pharmaceutical Nifedipine Injection Product Portfolio Table 95. Cisen Pharmaceutical Recent Development Table 96. Wuhan Binhu Shuanghe Pharmaceutical Company Information Table 97. Wuhan Binhu Shuanghe Pharmaceutical Business Overview Table 98. Wuhan Binhu Shuanghe Pharmaceutical Nifedipine Injection Sales (L), Revenue (US$ Million), Price (US$/ml) and Gross Margin (2021-2026) Table 99. Wuhan Binhu Shuanghe Pharmaceutical Nifedipine Injection Product Portfolio Table 100. Wuhan Binhu Shuanghe Pharmaceutical Recent Development Table 101. Bayer Company Information Table 102. Bayer Business Overview Table 103. Bayer Nifedipine Injection Sales (L), Revenue (US$ Million), Price (US$/ml) and Gross Margin (2021-2026) Table 104. Bayer Nifedipine Injection Product Portfolio Table 105. Bayer Recent Development Table 106. Pharmaoffer Company Information Table 107. Pharmaoffer Business Overview Table 108. Pharmaoffer Nifedipine Injection Sales (L), Revenue (US$ Million), Price (US$/ml) and Gross Margin (2021-2026) Table 109. Pharmaoffer Nifedipine Injection Product Portfolio Table 110. Pharmaoffer Recent Development Table 111. AdvaCare Company Information Table 112. AdvaCare Business Overview Table 113. AdvaCare Nifedipine Injection Sales (L), Revenue (US$ Million), Price (US$/ml) and Gross Margin (2021-2026) Table 114. AdvaCare Nifedipine Injection Product Portfolio Table 115. AdvaCare Recent Development Table 116. North America Nifedipine Injection Market Size Growth Rate (CAGR) by Country (L): 2021 VS 2025 VS 2032 Table 117. North America Nifedipine Injection Sales by Country (2021-2026) & (L) Table 118. North America Nifedipine Injection Sales Market Share by Country (2021-2026) Table 119. North America Nifedipine Injection Sales Forecast by Country (2027-2032) & (L) Table 120. North America Nifedipine Injection Sales Market Share Forecast by Country (2027-2032) Table 121. North America Nifedipine Injection Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 122. North America Nifedipine Injection Market Size by Country (2021-2026) & (US$ Million) Table 123. North America Nifedipine Injection Market Share by Country (2021-2026) Table 124. North America Nifedipine Injection Market Size Forecast by Country (2027-2032) & (US$ Million) Table 125. North America Nifedipine Injection Market Share Forecast by Country (2027-2032) Table 126. Europe Nifedipine Injection Market Size Growth Rate (CAGR) by Country (L): 2021 VS 2025 VS 2032 Table 127. Europe Nifedipine Injection Sales by Country (2021-2026) & (L) Table 128. Europe Nifedipine Injection Sales Market Share by Country (2021-2026) Table 129. Europe Nifedipine Injection Sales Forecast by Country (2027-2032) & (L) Table 130. Europe Nifedipine Injection Sales Market Share Forecast by Country (2027-2032) Table 131. Europe Nifedipine Injection Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 132. Europe Nifedipine Injection Market Size by Country (2021-2026) & (US$ Million) Table 133. Europe Nifedipine Injection Market Share by Country (2021-2026) Table 134. Europe Nifedipine Injection Market Size Forecast by Country (2027-2032) & (US$ Million) Table 135. Europe Nifedipine Injection Market Share Forecast by Country (2027-2032) Table 136. Asia-Pacific Nifedipine Injection Market Size Growth Rate (CAGR) by Country (L): 2021 VS 2025 VS 2032 Table 137. Asia-Pacific Nifedipine Injection Sales by Country (2021-2026) & (L) Table 138. Asia-Pacific Nifedipine Injection Sales Market Share by Country (2021-2026) Table 139. Asia-Pacific Nifedipine Injection Sales Forecast by Country (2027-2032) & (L) Table 140. Asia-Pacific Nifedipine Injection Sales Market Share Forecast by Country (2027-2032) Table 141. Asia-Pacific Nifedipine Injection Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 142. Asia-Pacific Nifedipine Injection Market Size by Country (2021-2026) & (US$ Million) Table 143. Asia-Pacific Nifedipine Injection Market Share by Country (2021-2026) Table 144. Asia-Pacific Nifedipine Injection Market Size Forecast by Country (2027-2032) & (US$ Million) Table 145. Asia-Pacific Nifedipine Injection Market Share Forecast by Country (2027-2032) Table 146. Latin America Nifedipine Injection Market Size Growth Rate (CAGR) by Country (L): 2021 VS 2025 VS 2032 Table 147. Latin America Nifedipine Injection Sales by Country (2021-2026) & (L) Table 148. Latin America Nifedipine Injection Sales Market Share by Country (2021-2026) Table 149. Latin America Nifedipine Injection Sales Forecast by Country (2027-2032) & (L) Table 150. Latin America Nifedipine Injection Sales Market Share Forecast by Country (2027-2032) Table 151. Latin America Nifedipine Injection Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 152. Latin America Nifedipine Injection Market Size by Country (2021-2026) & (US$ Million) Table 153. Latin America Nifedipine Injection Market Share by Country (2021-2026) Table 154. Latin America Nifedipine Injection Market Size Forecast by Country (2027-2032) & (US$ Million) Table 155. Latin America Nifedipine Injection Market Share Forecast by Country (2027-2032) Table 156. Middle East and Africa Nifedipine Injection Market Size Growth Rate (CAGR) by Country (L): 2021 VS 2025 VS 2032 Table 157. Middle East and Africa Nifedipine Injection Sales by Country (2021-2026) & (L) Table 158. Middle East and Africa Nifedipine Injection Sales Market Share by Country (2021-2026) Table 159. Middle East and Africa Nifedipine Injection Sales Forecast by Country (2027-2032) & (L) Table 160. Middle East and Africa Nifedipine Injection Sales Market Share Forecast by Country (2027-2032) Table 161. Middle East and Africa Nifedipine Injection Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 162. Middle East and Africa Nifedipine Injection Market Size by Country (2021-2026) & (US$ Million) Table 163. Middle East and Africa Nifedipine Injection Market Share by Country (2021-2026) Table 164. Middle East and Africa Nifedipine Injection Market Size Forecast by Country (2027-2032) & (US$ Million) Table 165. Middle East and Africa Nifedipine Injection Market Share Forecast by Country (2027-2032) Table 166. Key Raw Materials Table 167. Raw Materials Key Suppliers Table 168. Nifedipine Injection Distributors List Table 169. Nifedipine Injection Customers List Table 170. Research Programs/Design for This Report Table 171. Authors List of This Report Table 172. Secondary Sources Table 173. Primary Sources List of Figures Figure 1. Nifedipine Injection Image Figure 2. Global Nifedipine Injection Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Nifedipine Injection Market Size (2021-2032) & (US$ Million) Figure 4. Global Nifedipine Injection Sales (2021-2032) & (L) Figure 5. 10mg/2ml Image Figure 6. Global 10mg/2ml Sales YoY Growth (2021-2032) & (L) Figure 7. 20mg/2ml Image Figure 8. Global 20mg/2ml Sales YoY Growth (2021-2032) & (L) Figure 9. Global Nifedipine Injection Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Nifedipine Injection Market Share by Type 2025 VS 2032 Figure 11. North America Nifedipine Injection Sales Market Share in Volume by Type in 2025 Figure 12. North America Nifedipine Injection Sales Market Share in Value by Type in 2025 Figure 13. Europe Nifedipine Injection Sales Market Share in Volume by Type in 2025 Figure 14. Europe Nifedipine Injection Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Nifedipine Injection Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Nifedipine Injection Sales Market Share in Value by Type in 2025 Figure 17. Latin America Nifedipine Injection Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Nifedipine Injection Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Nifedipine Injection Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Nifedipine Injection Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Nifedipine Injection Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Hypertension Image Figure 24. Global Hypertension Sales YoY Growth (2021-2032) & (L) Figure 25. Angina (Chest Pain) Image Figure 26. Global Angina (Chest Pain) Sales YoY Growth (2021-2032) & (L) Figure 27. Global Nifedipine Injection Market Size Overview by Application (2021-2032) & (US$ Million) Figure 28. Global Nifedipine Injection Market Share by Application 2025 VS 2032 Figure 29. North America Nifedipine Injection Sales Market Share in Volume by Application in 2025 Figure 30. North America Nifedipine Injection Sales Market Share in Value by Application in 2025 Figure 31. Europe Nifedipine Injection Sales Market Share in Volume by Application in 2025 Figure 32. Europe Nifedipine Injection Sales Market Share in Value by Application in 2025 Figure 33. Asia-Pacific Nifedipine Injection Sales Market Share in Volume by Application in 2025 Figure 34. Asia-Pacific Nifedipine Injection Sales Market Share in Value by Application in 2025 Figure 35. Latin America Nifedipine Injection Sales Market Share in Volume by Application in 2025 Figure 36. Latin America Nifedipine Injection Sales Market Share in Value by Application in 2025 Figure 37. Middle East and Africa Nifedipine Injection Sales Market Share in Volume by Application in 2025 Figure 38. Middle East and Africa Nifedipine Injection Sales Market Share in Value by Application in 2025 Figure 39. North America Nifedipine Injection Sales by Country: 2021 VS 2025 VS 2032 (L) Figure 40. North America Nifedipine Injection Sales Share by Country: 2021 VS 2025 VS 2032 Figure 41. North America Nifedipine Injection Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 42. North America Nifedipine Injection Market Share by Country: 2021 VS 2025 VS 2032 Figure 43. Europe Nifedipine Injection Sales by Country: 2021 VS 2025 VS 2032 (L) Figure 44. Europe Nifedipine Injection Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Nifedipine Injection Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. Europe Nifedipine Injection Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Asia-Pacific Nifedipine Injection Sales by Country: 2021 VS 2025 VS 2032 (L) Figure 48. Asia-Pacific Nifedipine Injection Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Nifedipine Injection Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Asia-Pacific Nifedipine Injection Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Latin America Nifedipine Injection Sales by Country: 2021 VS 2025 VS 2032 (L) Figure 52. Latin America Nifedipine Injection Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Nifedipine Injection Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Latin America Nifedipine Injection Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Middle East and Africa Nifedipine Injection Sales by Country: 2021 VS 2025 VS 2032 (L) Figure 56. Middle East and Africa Nifedipine Injection Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Nifedipine Injection Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Middle East and Africa Nifedipine Injection Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Nifedipine Injection Value Chain Figure 60. Key Raw Materials Price Figure 61. Manufacturing Cost Structure Figure 62. Nifedipine Injection Production Mode & Process Figure 63. Direct Comparison with Distribution Share Figure 64. Distributors Profiles Figure 65. Years Considered Figure 66. Research Process Figure 67. Key Executives Interviewed

Scope & coverage.

Types
  • 10mg/2ml
  • 20mg/2ml
Applications
  • Hypertension
  • Angina (Chest Pain)
Companies covered
  • Teva
  • Medcalo
  • Mylan
  • Pfizer
  • Cisen Pharmaceutical
  • Wuhan Binhu Shuanghe Pharmaceutical
  • Bayer
  • Pharmaoffer
  • AdvaCare

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Nifedipine Injection Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Nifedipine Injection Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Nifedipine Injection Market by Type
  6. 1.3.1 10mg/2ml
  7. 1.3.2 20mg/2ml
  8. 1.4 Global Nifedipine Injection Market Size by Type
  9. 1.4.1 Global Nifedipine Injection Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Nifedipine Injection Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Nifedipine Injection Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Nifedipine Injection Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Nifedipine Injection Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Nifedipine Injection Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Nifedipine Injection Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Nifedipine Injection Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Nifedipine Injection Industry Trends
  2. 2.2 Nifedipine Injection Industry Drivers
  3. 2.3 Nifedipine Injection Industry Opportunities and Challenges
  4. 2.4 Nifedipine Injection Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Nifedipine Injection Revenue (2021-2026)
  2. 3.2 Global Top Players by Nifedipine Injection Sales (2021-2026)
  3. 3.3 Global Top Players by Nifedipine Injection Price (2021-2026)
  4. 3.4 Global Nifedipine Injection Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Nifedipine Injection Major Company Production Sites & Headquarters
  6. 3.6 Global Nifedipine Injection Company, Product Type & Application
  7. 3.7 Global Nifedipine Injection Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Nifedipine Injection Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Nifedipine Injection Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Nifedipine Injection Tier 1, Tier 2, and Tier 3
4 Nifedipine Injection Regional Status and Outlook
  1. 4.1 Global Nifedipine Injection Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Nifedipine Injection Historic Market Size by Region
  3. 4.2.1 Global Nifedipine Injection Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Nifedipine Injection Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Nifedipine Injection Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Nifedipine Injection Forecasted Market Size by Region
  7. 4.3.1 Global Nifedipine Injection Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Nifedipine Injection Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Nifedipine Injection Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Nifedipine Injection by Application
  1. 5.1 Nifedipine Injection Market by Application
  2. 5.1.1 Hypertension
  3. 5.1.2 Angina (Chest Pain)
  4. 5.2 Global Nifedipine Injection Market Size by Application
  5. 5.2.1 Global Nifedipine Injection Market Size Overview by Application (2021-2032)
  6. 5.2.2 Global Nifedipine Injection Historic Market Size Review by Application (2021-2026)
  7. 5.2.3 Global Nifedipine Injection Forecasted Market Size by Application (2027-2032)
  8. 5.3 Key Regions Market Size by Application
  9. 5.3.1 North America Nifedipine Injection Sales Breakdown by Application (2021-2026)
  10. 5.3.2 Europe Nifedipine Injection Sales Breakdown by Application (2021-2026)
  11. 5.3.3 Asia-Pacific Nifedipine Injection Sales Breakdown by Application (2021-2026)
  12. 5.3.4 South America Nifedipine Injection Sales Breakdown by Application (2021-2026)
  13. 5.3.5 Middle East and Africa Nifedipine Injection Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Teva
  2. 6.1.1 Teva Company Information
  3. 6.1.2 Teva Business Overview
  4. 6.1.3 Teva Nifedipine Injection Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Teva Nifedipine Injection Product Portfolio
  6. 6.1.5 Teva Recent Developments
  7. 6.2 Medcalo
  8. 6.2.1 Medcalo Company Information
  9. 6.2.2 Medcalo Business Overview
  10. 6.2.3 Medcalo Nifedipine Injection Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Medcalo Nifedipine Injection Product Portfolio
  12. 6.2.5 Medcalo Recent Developments
  13. 6.3 Mylan
  14. 6.3.1 Mylan Company Information
  15. 6.3.2 Mylan Business Overview
  16. 6.3.3 Mylan Nifedipine Injection Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Mylan Nifedipine Injection Product Portfolio
  18. 6.3.5 Mylan Recent Developments
  19. 6.4 Pfizer
  20. 6.4.1 Pfizer Company Information
  21. 6.4.2 Pfizer Business Overview
  22. 6.4.3 Pfizer Nifedipine Injection Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Pfizer Nifedipine Injection Product Portfolio
  24. 6.4.5 Pfizer Recent Developments
  25. 6.5 Cisen Pharmaceutical
  26. 6.5.1 Cisen Pharmaceutical Company Information
  27. 6.5.2 Cisen Pharmaceutical Business Overview
  28. 6.5.3 Cisen Pharmaceutical Nifedipine Injection Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Cisen Pharmaceutical Nifedipine Injection Product Portfolio
  30. 6.5.5 Cisen Pharmaceutical Recent Developments
  31. 6.6 Wuhan Binhu Shuanghe Pharmaceutical
  32. 6.6.1 Wuhan Binhu Shuanghe Pharmaceutical Company Information
  33. 6.6.2 Wuhan Binhu Shuanghe Pharmaceutical Business Overview
  34. 6.6.3 Wuhan Binhu Shuanghe Pharmaceutical Nifedipine Injection Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Wuhan Binhu Shuanghe Pharmaceutical Nifedipine Injection Product Portfolio
  36. 6.6.5 Wuhan Binhu Shuanghe Pharmaceutical Recent Developments
  37. 6.7 Bayer
  38. 6.7.1 Bayer Company Information
  39. 6.7.2 Bayer Business Overview
  40. 6.7.3 Bayer Nifedipine Injection Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Bayer Nifedipine Injection Product Portfolio
  42. 6.7.5 Bayer Recent Developments
  43. 6.8 Pharmaoffer
  44. 6.8.1 Pharmaoffer Company Information
  45. 6.8.2 Pharmaoffer Business Overview
  46. 6.8.3 Pharmaoffer Nifedipine Injection Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Pharmaoffer Nifedipine Injection Product Portfolio
  48. 6.8.5 Pharmaoffer Recent Developments
  49. 6.9 AdvaCare
  50. 6.9.1 AdvaCare Company Information
  51. 6.9.2 AdvaCare Business Overview
  52. 6.9.3 AdvaCare Nifedipine Injection Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 AdvaCare Nifedipine Injection Product Portfolio
  54. 6.9.5 AdvaCare Recent Developments
7 North America by Country
  1. 7.1 North America Nifedipine Injection Sales by Country
  2. 7.1.1 North America Nifedipine Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Nifedipine Injection Sales by Country (2021-2026)
  4. 7.1.3 North America Nifedipine Injection Sales Forecast by Country (2027-2032)
  5. 7.2 North America Nifedipine Injection Market Size by Country
  6. 7.2.1 North America Nifedipine Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Nifedipine Injection Market Size by Country (2021-2026)
  8. 7.2.3 North America Nifedipine Injection Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Nifedipine Injection Sales by Country
  2. 8.1.1 Europe Nifedipine Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Nifedipine Injection Sales by Country (2021-2026)
  4. 8.1.3 Europe Nifedipine Injection Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Nifedipine Injection Market Size by Country
  6. 8.2.1 Europe Nifedipine Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Nifedipine Injection Market Size by Country (2021-2026)
  8. 8.2.3 Europe Nifedipine Injection Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Nifedipine Injection Sales by Country
  2. 9.1.1 Asia-Pacific Nifedipine Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Nifedipine Injection Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Nifedipine Injection Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Nifedipine Injection Market Size by Country
  6. 9.2.1 Asia-Pacific Nifedipine Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Nifedipine Injection Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Nifedipine Injection Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Nifedipine Injection Sales by Country
  2. 10.1.1 South America Nifedipine Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Nifedipine Injection Sales by Country (2021-2026)
  4. 10.1.3 South America Nifedipine Injection Sales Forecast by Country (2027-2032)
  5. 10.2 South America Nifedipine Injection Market Size by Country
  6. 10.2.1 South America Nifedipine Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Nifedipine Injection Market Size by Country (2021-2026)
  8. 10.2.3 South America Nifedipine Injection Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Nifedipine Injection Sales by Country
  2. 11.1.1 Middle East and Africa Nifedipine Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Nifedipine Injection Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Nifedipine Injection Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Nifedipine Injection Market Size by Country
  6. 11.2.1 Middle East and Africa Nifedipine Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Nifedipine Injection Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Nifedipine Injection Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Nifedipine Injection Value Chain Analysis
  2. 12.1.1 Nifedipine Injection Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Nifedipine Injection Production Mode & Process
  7. 12.2 Nifedipine Injection Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Nifedipine Injection Distributors
  10. 12.2.3 Nifedipine Injection Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research